Michelle Wang

Co-Founder and Partner at Lair East Labs

📍 New York, New York, United States🔄 Updated September 2026💼 18 investments📅 7 years investing🗓 Last invested Oct 2025
Operator-angel🌍 United StatesInvested this year
18
Total investments
9
Early stage
7
Mid stage
0
Late stage
7y
Years active

Portfolio

18 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Oct 2025
Quantivly is building AI for imaging operations, not clinical diagnosis. Radiology departments operate in the same way airlines did in 1981, with no access to operational data such as jet engine performance, wind statistics, etc.  Similarly, imaging facilities today critically lack access to operational data to manage their multi-million-dollar MRI scanners, leading to a true operational black hole and decisions based on gut feeling instead of data. The Quantivly platform analyzes, cleans, and harmonizes scanner data to build the first queryable, vendor-neutral, highly granular source of knowledge about operations. It is not just about what was scheduled; it is also about what really happened on your scanners. Quantivly further leverages AI to augment the information and capture data previously unavailable, including repeat detection, image quality quantification, and smart recommendations. Armed with data, leaders can justify MR operations decisions, capital purchases, staffing needs, workflow changes and quantify the success of their decisions and interventions with metrics. AI promised to revolutionize diagnosis in Radiology, but adoption has been slow with minimal impact on patient care in many clinical scenarios. Quantivly instead focuses on an urgent problem of discovering operational patterns and help optimize operations, increase patient access, and improve patient satisfaction. We unlock a new world of data analytics for imaging facilities. And this is just the beginning. We have an exciting roadmap.
Investor
Oct 2022
Clearing is an expense & revenue management platform tailored for Short-Term Rental operators to automate bookkeeping, reconcile bank accounts 10x faster and pay homeowners and vendors in one click. NY based & VC-backed.
Investor
Aug 2021
FRANK is a design platform embedded with architectural intelligence, allowing anyone to make well-designed homes that fit their exact needs. Frank provides a better way for people to design their custom homes. We believe that a good design shouldn’t have to be a luxury!
early stageDesign Services
Investor
Jul 2021
Modality.ai provides multimodal technology for the objective assessment of CNS conditions through automated speech and visual analytics of conversations elicited by Tina, a virtual guide. Our platform is used in clinic and remotely in IRB approved studies generating over 20,000 recorded sessions to date. Modality is led by a team of world-class scientists, clinicians, technologists, and serial entrepreneurs, and has shown clinical validation through numerous peer-reviewed publications.
Investor
May 2021
Genomelink is a DNA App Store where people upload and store DNA data to access more insights, products, and health research. We are on missions to; - Build a world #1 consumer application platform - Help advancement of genomics and health science - Bring back DNA data ownership to your hand
mid stageBiotechnology
Investor
Dec 2020
Visual Feeder (VF) is a media tech company that deploys next generation brand activations and digital OOH using projection mapping technology.
Investor
Sep 2020
Alteron Therapeutics is a biotech startup dedicated to developing innovative drugs for the treatment Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS). We target high TDP-43 activity, which is the root cause of neuronal death.  By inhibiting TDP-43, out drugs can simultaneously eliminate the three pathological markers of neurodegeneration and their efficacy has been verified in an hTDP-43 transgenic mouse disease model.
Investor
Aug 2020
Drawing on the innovations born and bred at MIT and Harvard, coupled with thought leadership defining clinical trajectories, we are transforming disease management across hematology, cardiology, neurology and cancer.
Investor
Apr 2020
We are hiring new positions, feel free to contact us: Polymer Scientist, Protein Engineer, Marketing & Communication Manager, and more. Mi Terro is a venture-backed synthetic biology and advanced material company that engineers biomass waste into hydrophilic biopolymers to end microplastic through precision fermentation – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our product is patented and USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim to maximize the use of side streams, second-generation (non-food feedstock), and certified biomasses. We are not turning agricultural waste into beverage or snack like other companies. Instead, we use A.I. to re-engineer biopolymers from low-value wastes to replace single-use microplastic and petrochemical textile fiber while giving additional incomes to farmers all around the world. While bio-based, Mi Terro materials do not compete with food production, thereby preventing land-use change. In contrast to conventional (bio)plastics, we do not need any harmful additives, solvents, or chemicals and have up to 90% lower CO2 emissions.
early stageBiotechnology
Investor
Apr 2020
At Lilu we build tech-enabled products to empower new moms. Were building a platform of smart products that leverage cutting edge technologies to make postpartum care more comfortable, efficient and pain-free Visit our website to learn more: https://www.wearlilu.com
Investor
Apr 2020
Alexapath Company Profile Bringing metamorphic transformation in the field of medical diagnosis and research, Alexapath has brought along ground-breaking revolution. Envisioned with the future of digital microscopy, and empowered by artificial intelligence Alexapath offers AiDA 2 microscope. With the infusion of inventory expertise by mobile Whole Slide Imaging developers, AiDA2 microscope is one of its kind with its astounding built-in dynamic, archival, and AI capabilities. Transforming medical research, AI-empowered AiDA 2 microscope by Alexapath is competent to scan various types of slides and brings in effective automation of routine lab workflows. With dynamic and PACS-based tele-pathology, our team of brainy geniuses have unleashed the towering supremacy of AI. Our most sought-after AI-enabled, futuristic solutions are recognized for: AI in Healthcare Healthcare consulting Digital Pathology Digital Healthcare Robotics in Healthcare Having a sound technological dominance ushered in our every approach, we are building an extensive tele-pathology network. Our experts onboard offer reliable cytology consultation and assist eminently in deploying artificial intelligence in a digital pathology setting. Endowed with rich experiences, Alexapath is expanding in its business horizons thereby partnering with experts and creating solutions for better healthcare. Here we are a few key highlights of our crowned partnerships: Validation of mobile Whole Slide Imaging (mWSI) with Northwell Health, Usa Furbishing network for diagnosis of childhood cancers in Tanzania with Oxford University ,UK & Tumaini La Maisha ,Tanzania with AiDA 2 AI-enabled microscope. Mobile Pre-screening for Cervical Cancer with Qualcomm, India Detection of single cells parasites in water empowered by HEAD AI with UNAM, Mexico Bringing accessible parasite testing for farm animals with v Hive & Zoetis Chasing maximum recognition, Alexapath team is endeavouring to project the bright scope of future under our lenses of expertise with consistent contribution for water, clinical and veterinary testing. With more such eminent footsteps in the field of digital healthcare, Alexapath is crafting revolutionary future models for the better tomorrow.
Investor
Aug 2019
BallBox is revolutionizing the transfer of goods with lockers & logistics. BallBox is the only kiosk that can be used for package management as well as product discovery, sampling, rentals and purchases. BallBox leverages the traffic driven by package pick ups to give brands amazing opportunities to get real product in peoples hands, creating an experiential product discovery network and marketplace.
early stageRetail
Investor
Jul 2019
AltaClaro is the leading provider of experiential bootcamps for lawyers and law students. Our programs are training attorneys and students inside some of the world’s leading law firms and law schools. Our unique learn-by-doing and feedback model helps attorneys become practice-ready at an accelerated pace, empowering participants to own their career trajectory and helping law firms to drastically reduce the costs associated with training.
mid stageE-learning
Investor
Jul 2019
Whether travel is for business or pleasure, Rene is the app that makes the world your comfort zone, Rene reduces the risk and uncertainty that comes with modern travel. Input your itinerary and Rene’s algorithm gets to work, matching your trip to the right type of travel insurance policy while providing the resources you’d need in case of an emergency. You’ll get essential real-time information about travel restrictions and advisories before and during your arrival, access to 24/7 telemedicine, health insurance and medical evacuation. Rene provides a high degree of confidence and security in a friendly, approachable interface. Rene is the perfect plaform for travel managers and agencies, helping them comply with their duty of care regulations and monitoring risk while helping improve travel policies and outcomes.
early stageInsurance
Show all 18 investments ↓
Experience · 19 entries
All (19)
Investments (18)
Founder (1)
2025
Seed Investor
Oct 2025
Quantivly is building AI for imaging operations, not clinical diagnosis. Radiology departments operate in the same way airlines did in 1981, with no access to operational data such as jet engine performance, wind statistics, etc.  Similarly, imaging facilities today critically lack access to operational data to manage their multi-million-dollar MRI scanners, leading to a true operational black hole and decisions based on gut feeling instead of data. The Quantivly platform analyzes, cleans, and harmonizes scanner data to build the first queryable, vendor-neutral, highly granular source of knowledge about operations. It is not just about what was scheduled; it is also about what really happened on your scanners. Quantivly further leverages AI to augment the information and capture data previously unavailable, including repeat detection, image quality quantification, and smart recommendations. Armed with data, leaders can justify MR operations decisions, capital purchases, staffing needs, workflow changes and quantify the success of their decisions and interventions with metrics. AI promised to revolutionize diagnosis in Radiology, but adoption has been slow with minimal impact on patient care in many clinical scenarios. Quantivly instead focuses on an urgent problem of discovering operational patterns and help optimize operations, increase patient access, and improve patient satisfaction. We unlock a new world of data analytics for imaging facilities. And this is just the beginning. We have an exciting roadmap.
2022
Investor
Oct 2022
Clearing is an expense & revenue management platform tailored for Short-Term Rental operators to automate bookkeeping, reconcile bank accounts 10x faster and pay homeowners and vendors in one click. NY based & VC-backed.
2021
Investor
Aug 2021
FRANK is a design platform embedded with architectural intelligence, allowing anyone to make well-designed homes that fit their exact needs. Frank provides a better way for people to design their custom homes. We believe that a good design shouldn’t have to be a luxury!
early stageDesign Services
Investor
Jul 2021
Modality.ai provides multimodal technology for the objective assessment of CNS conditions through automated speech and visual analytics of conversations elicited by Tina, a virtual guide. Our platform is used in clinic and remotely in IRB approved studies generating over 20,000 recorded sessions to date. Modality is led by a team of world-class scientists, clinicians, technologists, and serial entrepreneurs, and has shown clinical validation through numerous peer-reviewed publications.
Investor
May 2021
Genomelink is a DNA App Store where people upload and store DNA data to access more insights, products, and health research. We are on missions to; - Build a world #1 consumer application platform - Help advancement of genomics and health science - Bring back DNA data ownership to your hand
mid stageBiotechnology
Show all 19 entries ↓
Investment activity
2019–2025 · 18 investments
2019620207202132022120251
Recent (last 2 years)Earlier